Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

SHA:603207 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	913.76	883.43	285.54	58.66	44.81	52.06
Short-Term Investments	-	-	-	1.31	5.08	-
Trading Asset Securities	-	-	2.97	108.96	158.11	60.63
Cash & Short-Term Investments	913.76	883.43	288.52	168.93	208.01	112.69
Cash Growth	216.71%	206.20%	70.79%	-18.79%	84.58%	-3.42%
Accounts Receivable	94.95	90.29	85.39	81.88	55.82	70
Other Receivables	0.48	2.21	2.06	0.82	0.72	3.73
Receivables	95.43	92.5	87.46	82.69	56.55	73.74
Inventory	43.66	45.21	49.9	57.2	53.37	40.22
Other Current Assets	9.75	10.8	26.19	19.04	8.45	3.98
Total Current Assets	1,063	1,032	452.06	327.87	326.37	230.63
Property, Plant & Equipment	340.73	338.04	226.57	62.97	25.75	14.52
Long-Term Investments	-	-	-	-	1.27	6.19
Other Intangible Assets	24.13	24.53	26.12	27.7	29.23	30.81
Long-Term Deferred Tax Assets	2.51	3.36	2.86	2.27	2	1.44
Long-Term Deferred Charges	1.24	1.32	0.47	0.49	0.74	0.62
Other Long-Term Assets	2.87	3.26	4.58	42	0.67	0.38
Total Assets	1,434	1,402	712.65	463.3	386.02	284.58
Accounts Payable	23.52	23.09	19.61	27.42	16.61	22.12
Accrued Expenses	6.14	36.34	38.38	28.91	34.34	30.33
Short-Term Debt	0.51	1.65	-	-	-	-
Current Portion of Leases	0.67	0.67	0.42	-	-	-
Current Income Taxes Payable	9.6	7.13	5.33	12.5	13.71	12.87
Current Unearned Revenue	0.44	0.89	0.61	1.55	11.79	1.29
Other Current Liabilities	98.96	98.38	67.82	19.58	79.09	2.26
Total Current Liabilities	139.85	168.15	132.18	89.96	155.55	68.86
Long-Term Leases	-	-	0.44	0.88	1.27	-
Long-Term Unearned Revenue	0.06	0.07	0.08	0.09	0.1	0.12
Total Liabilities	139.91	168.21	132.7	90.94	156.92	68.97
Common Stock	160.56	160	120	120	120	32
Additional Paid-In Capital	486.15	478.23	69.22	65.25	61.18	0.25
Retained Earnings	655.85	596.01	390.73	187.11	47.93	183.36
Shareholders' Equity	1,294	1,234	579.95	372.36	229.11	215.61
Total Liabilities & Equity	1,434	1,402	712.65	463.3	386.02	284.58
Total Debt	1.18	2.32	0.86	0.88	1.27	-
Net Cash (Debt)	912.58	881.11	287.65	168.05	206.74	112.69
Net Cash Growth	217.25%	206.31%	71.17%	-18.71%	83.45%	-3.42%
Net Cash Per Share	6.30	6.57	2.40	1.40	1.72	-
Filing Date Shares Outstanding	160.56	160.56	160	120	120	-
Total Common Shares Outstanding	160.56	160	120	120	120	-
Working Capital	922.75	863.79	319.89	237.9	170.83	161.77
Book Value Per Share	8.06	7.71	4.83	3.10	1.91	-
Tangible Book Value	1,270	1,210	553.84	344.66	199.88	184.8
Tangible Book Value Per Share	7.91	7.56	4.62	2.87	1.67	-
Buildings	-	26.35	26.35	26.35	25.62	25.9
Machinery	-	36.94	35.52	35.19	32.62	31.75
Construction In Progress	-	329.17	216.53	50.04	12.67	0.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.